Appointments at inVentiv, Icon, ICTS, OSO and Warnex – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Inventiv health Private equity firm Management occupations Corporate governance

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at inVentiv, Icon, ICTS, OSO and Warnex.

Paul Meister​, executive chairman of inVentiv Health​, has been made CEO of the company. Meister is founder and CEO of Liberty Lane Partners, a private equity firm involved in the August 2010 takeover of inVentiv.

From 1991 to 2006 Meister was an executive officer at Fisher Scientific.

Icon ​has appointed Anthony Priestley​ as medical director at its clinical pharmacology unit in Manchester, UK. Priestly has previously worked at LCG Bioscience and Serono.

Sheila Ogle​ has resigned as CEO of patient recruitment specialist ICTS​. Ogle has worked at ICTS for eight years and will be replaced by Tom Sturgis​, the company’s president.

OSO BioPharmaceuticals Manufacturing ​has named Craig Mastenbaum​ as director of new business development for the US West Coast market. Mastenbaum has more than 30 years of manufacturing experience working at Hollister-Stier Laboratories and Chiron.

Erik Yelle​ has left Warnex Analytical Services​. Yelle worked as vice president (VP), operations but has left to pursue other interests. Mark Busgang​, president and CEO of the company, will assume Yelle’s responsibilities in the near term.

WaferGen Biosystems​ has elected Arul Chinnaiyan​ to its scientific advisory board. Chinnaiyan is a clinical genomics cancer researcher experienced in the use of biomarkers.

Roger Hayes​ has joined Cetero Research​ as president, bioanalytical operations. Hayes is a former employee of Schering-Plough and, after the acquisition, Merck & Co with 15 years of experience.

Biopharm Services​ has appointed Udo Vetter​ and Nigel Titchener​ to advise its board of directors on business strategy. Vetter is chairman of the board at Vetter Pharma and a member of the supervisory board at Gerresheimer.

Wolfgang Noe​ has been named as a senior consultant at BioProcess Technology Consultants​. Noe most recently worked as VP, strategic development and technical alliance at Biogen Idec.

Related topics Markets & Regulations

Related news

Show more